Dr. Kai McGreevy, MD

Dr. McGreevy practices at Mcgreevy Neurohealth in Saint Augustine, Florida.

Dr. McGreevy's NPI, 1922208610, was assigned on July 20, 2007. Dr. McGreevy graduated from American University of the Caribbean School of Medicine in 2006. Dr. McGreevy holds Florida license ME109028.

Dr. McGreevy's primary practice is Mcgreevy Neurohealth, at 559 W Twincourt Trl Unit 607 Unit 607, Saint Augustine, FL 32095-8805. The practice phone is (904) 230-3006.

Dr. McGreevy's primary practice is Mcgreevy Neurohealth in Saint Augustine, Florida. Dr. McGreevy is also affiliated with UF Health Flagler Hospital. The medical group on file is McGreevy NeuroHealth. Dmand AI also links Dr. McGreevy to 5 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGreevy practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. McGreevy's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. McGreevy is board certified in brain injury medicine by the American Board of Psychiatry and Neurology. Dmand AI has Dr. McGreevy's licenses on file in 3 states: Florida, California and Georgia.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, encephalopathy, essential tremor, fibromyalgia and chronic pain, head injury and hereditary polyneuropathy among the conditions Dr. McGreevy treats.

CMS data shows 67,818 Medicare services from Dr. McGreevy across 80 procedure codes in 2024, for 797 Medicare patients. Medicare paid $1,872,347 for them.

CMS counts 797 Medicare patients who saw Dr. McGreevy in 2024. The largest group is 75 to 84, with 361 patients. 75% of them have arthritis, and 75% have bipolar disorder. 2% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McGreevy's median patient age at 70, with 55% women.

In 2024, Dr. McGreevy wrote 5,251 Medicare Part D claims for 696 patients. 97% of them were for generic drugs. CMS names the drug for 5,036 of them, across 59 drugs with 11 or more claims each, at $203,531 in total drug cost. In 2023, CMS named 4,973 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. McGreevy for performance year 2024, reported individually. Dr. McGreevy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGreevy as offering telehealth. CMS counts 97 procedures of varicose vein removal by Dr. McGreevy, more than 83% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. McGreevy in 2012. The most frequent topics are Electric Stimulation Therapy, Neuralgia and Chronic Pain. Dr. McGreevy has published most often in Curr Pain Headache Rep. Dr. McGreevy's most frequent co-authors are Kayode Ayodele Williams, MD, Paul Jordan Christo, MD and Farshad M. Ahadian, MD.

CMS Open Payments shows 551 general payments to Dr. McGreevy from 83 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Boston Scientific Corporation paid the most, $3,090.

Dr. McGreevy graduated from American University of the Caribbean School of Medicine in 2006.

Dr. McGreevy is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.